Little enhancement of meal-induced glucagon-like peptide 1 secretion in Japanese: Comparison of type 2 diabetes patients and healthy controls

被引:77
作者
Yabe, Daisuke [1 ]
Kuroe, Akira [1 ]
Lee, Soushou [2 ]
Watanabe, Koin [1 ]
Hyo, Takanori [1 ]
Hishizawa, Masahiro [1 ]
Kurose, Takeshi [1 ]
Deacon, Carolyn F. [3 ]
Holst, Jens J. [3 ]
Hirano, Tsutomu [2 ]
Inagaki, Nobuya [4 ]
Seino, Yutaka [1 ]
机构
[1] Kansai Elect Power Hosp, Div Diabet Clin Nutr & Endocrinol, Osaka, Japan
[2] Showa Univ, Sch Med, Dept Diabet Metab & Endocrinol, Tokyo 142, Japan
[3] Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark
[4] Kyoto Univ, Grad Sch Med, Dept Diabet & Clin Nutr, Kyoto, Japan
关键词
DPP-4; GIP; GLP-1; GASTRIC-INHIBITORY POLYPEPTIDE; INCRETIN RESPONSES; MELLITUS; INSULIN; GLUCOSE; PLASMA; DEGRADATION; PRODUCTS; EFFICACY; HORMONES;
D O I
10.1111/j.2040-1124.2010.00010.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Although glucose-dependent insulinotropic polypeptide (GIP) levels have been characterized previously, GLP-1 levels in Asians remain unclear. Here, we investigate total and intact levels of GLP-1, as well as GIP during oral glucose and meal tolerance tests (OGTT and MTT) in Japanese patients with or without type 2 diabetes (T2DM). Seventeen Japanese healthy controls and 18 age-matched and untreated patients with T2DM of short duration participated in the present study. Fasting levels of total GPL-1 were similar between the two groups (approximately 15 pM), and intact GLP-1 levels were considerably low in both groups (less than 1 pM). In both groups, total GLP-1 reached a peak 30 min after glucose ingestion (30-40 pM), whereas intact GLP-1 levels remained low with no significant peak. In MTT, total and intact GLP-1 showed no obvious peak. The current data indicate that intact GLP-1 levels are considerably low in the Japanese and that meal-induced enhancement of GLP-1 secretion is negligible in the Japanese. (J Diabetes Invest, doi: 10.1111/j.2040-1124.2010.00010.x, 2010)
引用
收藏
页码:56 / 59
页数:4
相关论文
共 26 条
  • [21] INCRETIN EFFECT DUE TO INCREASED SECRETION AND DECREASED CLEARANCE OF INSULIN IN NORMAL HUMANS
    SHUSTER, LT
    GO, VLW
    RIZZA, RA
    OBRIEN, PC
    SERVICE, FJ
    [J]. DIABETES, 1988, 37 (02) : 200 - 203
  • [22] Thomsen C, 1999, AM J CLIN NUTR, V69, P1135
  • [23] Nutritional regulation of glucagon-like peptide-1 secretion
    Tolhurst, Gwen
    Reimann, Frank
    Gribble, Fiona M.
    [J]. JOURNAL OF PHYSIOLOGY-LONDON, 2009, 587 (01): : 27 - 32
  • [24] Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus
    Vilsboll, T
    Krarup, T
    Sonne, J
    Madsbad, S
    Volund, A
    Juul, AG
    Holst, JJ
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (06) : 2706 - 2713
  • [25] Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance
    Vollmer, Kirsten
    Holst, Jens J.
    Baher, Birgit
    Ellrichmann, Mark
    Nauck, Michael A.
    Schmidt, Wolfgang E.
    Meier, Juris J.
    [J]. DIABETES, 2008, 57 (03) : 678 - 687
  • [26] Pancreatic and extrapancreatic effects of gastric inhibitory polypeptide
    Yamada, Yuichiro
    Miyawaki, Kazumasa
    Tsukiyama, Katsushi
    Harada, Norio
    Yamada, Chizumi
    Seino, Yutaka
    [J]. DIABETES, 2006, 55 : S86 - S91